Molecular Partners AG engages in the provision of development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. It also develops its products through its brand known as DARPins, which targets specific and potent monoclonal antibodies that offers potential to address existing limitations of antibody drugs. The company products include Abicipar, MP0250/MP0274, and Clinical Trials. The company was founded by Christian Zahnd, Patrick Amstutz, Patrik Forrer, Andreas Plückthun, and Michael Tobias Stumpp on November 22, 2004 and is headquartered in Schlieren, Switzerland.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
174
Frequently Asked Questions
What is Market Cap of Molecular Partners AG?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Molecular Partners AG market cap is $130.87M.
What is the 52-week high for Molecular Partners AG?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Molecular Partners AG 52 week high is $6.70 as of September 26, 2025.
What is the 52-week low for Molecular Partners AG?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Molecular Partners AG 52 week low is $3.40 as of September 26, 2025.
What is Molecular Partners AG stock price today?
Molecular Partners AG stock price today is $3.50.
What was Molecular Partners AG stock price yesterday?
Molecular Partners AG stock price yesterday was $3.45.
What is the PE ratio of Molecular Partners AG?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Molecular Partners AG’s P/E ratio is -1.68.
What is the Price-to-Book ratio of Molecular Partners AG?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Molecular Partners AG P/B ratio is 0.9767.
What is the 50-day moving average of Molecular Partners AG?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Molecular Partners AG 50-day moving average is $4.05.
How many employess does Molecular Partners AG has?
